BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Souza MF, Cólus IMS, Fonseca AS, Antunes VC, Kumar D, Cavalli LR. MiR-182-5p Modulates Prostate Cancer Aggressive Phenotypes by Targeting EMT Associated Pathways. Biomolecules 2022;12:187. [DOI: 10.3390/biom12020187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Otmani K, Rouas R, Lewalle P. OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications. Front Immunol 2022;13:913951. [DOI: 10.3389/fimmu.2022.913951] [Reference Citation Analysis]
2 Hatmal MM, Al-hatamleh MAI, Olaimat AN, Alshaer W, Hasan H, Albakri KA, Alkhafaji E, Issa NN, Al-holy MA, Abderrahman SM, Abdallah AM, Mohamud R. Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects. Biomedicines 2022;10:1219. [DOI: 10.3390/biomedicines10061219] [Reference Citation Analysis]
3 Sugita BM, Rodriguez Y, Fonseca AS, Nunes Souza E, Kallakury B, Cavalli IJ, Ribeiro EMSF, Aneja R, Cavalli LR. MiR-150-5p Overexpression in Triple-Negative Breast Cancer Contributes to the In Vitro Aggressiveness of This Breast Cancer Subtype. Cancers (Basel) 2022;14:2156. [PMID: 35565284 DOI: 10.3390/cancers14092156] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]